#1 Clinical Trials Search in Europe

Piperacillin Sodium

Piperacillin Sodium is an antibiotic medication that has been the subject of various clinical trials to evaluate its effectiveness in treating different types of infections. This article explores the use of Piperacillin Sodium in clinical studies, focusing on its applications, dosing regimens, and potential benefits in combating bacterial infections across different patient populations.

Table of Contents

What is Piperacillin Sodium?

Piperacillin sodium is a powerful antibiotic medication used to treat various serious bacterial infections. It belongs to a class of antibiotics called penicillins, specifically extended-spectrum penicillins. Piperacillin works by stopping the growth of bacteria by interfering with their cell wall formation[1].

This medication is also known by other names, including:

  • PIPC (an abbreviation commonly used in medical settings)
  • Piperacillin (the base form of the drug)

What Conditions Does Piperacillin Sodium Treat?

Piperacillin sodium is used to treat a variety of serious bacterial infections, including:

  • Septic shock: A life-threatening condition caused by a severe infection that leads to dangerously low blood pressure[1]
  • Respiratory tract infections: Infections affecting the lungs, sinuses, or airways[2]
  • Urinary tract infections: Infections in any part of the urinary system, including the kidneys, bladder, or urethra[2]
  • Diabetic foot infections: Serious infections that can occur in people with diabetes, often affecting the feet[3]
  • Infections in patients with low white blood cell counts: These patients are at higher risk for severe infections due to a weakened immune system[4]

How is Piperacillin Sodium Administered?

Piperacillin sodium is typically given as an intravenous (IV) infusion, which means it’s administered directly into a vein. The dosage and frequency can vary depending on the specific condition being treated and the patient’s individual factors. Some common administration methods include:

  • Extended infusion over 3 hours, given every 8 hours[1]
  • Continuous infusion over 24 hours[1]
  • Multiple daily doses, such as every 6 or 8 hours[4]

The duration of treatment can range from a few days to several weeks, depending on the severity of the infection and the patient’s response to the medication.

Piperacillin in Combination with Other Drugs

Piperacillin is often combined with other medications to enhance its effectiveness or broaden its spectrum of activity against different types of bacteria. Common combinations include:

  • Piperacillin/Tazobactam: This combination is frequently used and is known by brand names such as Tazocin™. Tazobactam helps prevent certain bacteria from becoming resistant to piperacillin[3]
  • Piperacillin/Sulbactam: Another combination that helps combat antibiotic resistance[2]

Clinical Studies and Effectiveness

Several clinical studies have been conducted to evaluate the effectiveness of piperacillin sodium and its combinations:

  • A study comparing piperacillin/tazobactam to ertapenem for treating diabetic foot infections showed that both medications were effective in achieving clinical improvement or cure[3]
  • Research on extended-infusion protocols of piperacillin/tazobactam in patients with septic shock aimed to determine if this method could improve outcomes in critically ill patients[1]
  • A study evaluated the effectiveness of piperacillin/sulbactam for respiratory and urinary tract infections, focusing on its ability to clear bacteria from the body[2]

Potential Side Effects and Safety Concerns

Like all medications, piperacillin sodium can cause side effects. Common side effects may include:

  • Nausea or vomiting
  • Diarrhea
  • Headache
  • Skin rash or itching
  • Allergic reactions (in rare cases)

More serious side effects, though less common, can include severe allergic reactions, liver or kidney problems, or blood disorders. It’s important to report any unusual symptoms to your healthcare provider immediately[3].

Patients with a history of allergies to penicillin or other beta-lactam antibiotics should inform their doctor before receiving piperacillin sodium, as there may be a risk of cross-reactivity[5].

Aspect Details
Primary Uses Treatment of respiratory tract infections, urinary tract infections, diabetic foot infections, sepsis
Patient Populations Adults, neonates, pregnant women
Administration Intravenous (IV), typically every 6-8 hours
Common Dosages 1.5g to 4.5g, varying based on infection severity and patient factors
Combination Therapies Often combined with Tazobactam or Sulbactam to enhance effectiveness
Efficacy Measures Clinical improvement/cure rates, bacterial clearance, fever resolution, length of hospital stay
Safety Monitoring Adverse events, allergic reactions, liver and kidney function changes
Pharmacokinetic Studies Drug concentrations in blood and urine, clearance, volume of distribution
Special Considerations Dosing adjustments for neonates and patients with impaired renal function

FAQ

  • What is Piperacillin Sodium used for in clinical trials? Piperacillin Sodium is used in clinical trials to treat various infections, including respiratory tract infections, urinary tract infections, diabetic foot infections, and sepsis in different patient populations, including adults and neonates.
  • How is Piperacillin Sodium typically administered in clinical studies? In clinical trials, Piperacillin Sodium is usually administered intravenously (IV). The dosage and frequency can vary depending on the study and patient population, ranging from every 6 to 8 hours, with doses typically between 1.5g to 4.5g.
  • Are there any combination therapies involving Piperacillin Sodium being studied? Yes, Piperacillin Sodium is often studied in combination with other drugs. Common combinations include Piperacillin/Tazobactam and Piperacillin/Sulbactam, which are designed to enhance the antibiotic's effectiveness against resistant bacteria.
  • What are some potential side effects of Piperacillin Sodium observed in clinical trials? While specific side effects can vary, clinical trials often monitor for adverse events such as allergic reactions, skin rashes, changes in liver and kidney function, and gastrointestinal disturbances. The safety profile is typically assessed as part of the study outcomes.
  • How do researchers measure the effectiveness of Piperacillin Sodium in clinical trials? Researchers typically measure effectiveness through various outcomes, including clinical improvement or cure rates, bacterial clearance, time to fever resolution, length of hospital stay, and pharmacokinetic parameters such as drug concentrations in blood and urine.

Ongoing Clinical Trials on Piperacillin Sodium

  • Comparing pivmecillinam and gentamicin with standard treatments for hospitalized adults with complicated urinary tract infections

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

    Recruiting

    1 1 1
    Investigated drugs:
    Norway Sweden

  • Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway

  • Study on High-Dose Short-Course Antibiotics for Critically Ill Patients with Pneumonia, Intra-Abdominal, or Bloodstream Infections: Ceftriaxone, Linezolid, and Cefotaxime

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium The Netherlands

  • Study on Early Stopping of Antibiotics in Elderly Patients with Viral Infections Using Amoxicillin, Clavulanic Acid, Piperacillin, Tazobactam, and Pristinamycin

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Piperacillin/Tazobactam and Levofloxacin for Patients with COPD or Cystic Fibrosis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study on Antibiotic Prophylaxis with Piperacillin, Tazobactam, and Cefazolin for Burn Patients Undergoing Excision-Graft Surgery

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Post-Surgery Antibiotic Use for Patients with Biliary Stents Undergoing Pancreaticoduodenectomy: Piperacillin and Tazobactam Evaluation

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on Piperacillin-Tazobactam and Temocillin for Treating Severe Infections in ICU Patients with ESBL-Producing Gram-Negative Bacteria

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

Glossary

  • Piperacillin Sodium: An antibiotic medication used to treat various bacterial infections. It belongs to the penicillin class of antibiotics and works by inhibiting bacterial cell wall synthesis.
  • Tazobactam: A beta-lactamase inhibitor often combined with Piperacillin to enhance its effectiveness against certain antibiotic-resistant bacteria.
  • Intravenous (IV): A method of administering medication directly into a vein, allowing for rapid distribution throughout the body.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Clinical Trial: A research study that tests how well new medical approaches work in people, often used to evaluate the safety and efficacy of new drugs or treatments.
  • Sepsis: A life-threatening condition that occurs when the body's response to infection causes widespread inflammation and organ failure.
  • Bacterial Clearance: The elimination of bacteria from the body, often used as a measure of antibiotic effectiveness in clinical trials.
  • Adverse Event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.
  • Pharmacodynamics: The study of the biochemical and physiological effects of drugs on the body, including their mechanisms of action and relationship between drug concentration and effect.
  • Beta-lactamase: An enzyme produced by some bacteria that can break down certain antibiotics, including some penicillins, making the bacteria resistant to these drugs.

References

  1. https://clinicaltrials.gov/study/NCT02820987
  2. https://clinicaltrials.gov/study/NCT01760109
  3. https://clinicaltrials.gov/study/NCT01370616
  4. https://clinicaltrials.gov/study/NCT00003805
  5. https://clinicaltrials.gov/study/NCT01805856